NCT01616121View on ClinicalTrials.gov

Preemptive Lung Impedance-Guided Therapy in Evolving Acute Heart Failure in Acute Myocardial Infarction Patients

PHASE3CompletedINTERVENTIONAL

Enrollment

654

Participants

Timeline

Start Date

June 1, 2002

Primary Completion Date

July 1, 2014

Study Completion Date

July 1, 2014

Conditions

Heart Failure

Interventions

OTHER

Usual treatment of patients with developing acute heart failure

DEVICE

Lung Impedance-Guided Therapy

Non-invasive lung impedance monitor (RSMM Company, Tel Aviv, Israel)

Trial Locations (1)

38100

Hillel Yaffe Medical Center, Hadera

All Listed Sponsors

lead

Hillel Yaffe Medical Center

OTHER_GOV

NCT01616121 - Preemptive Lung Impedance-Guided Therapy in Evolving Acute Heart Failure in Acute Myocardial Infarction Patients | Biotech Hunter | Biotech Hunter